SAB Biotherapeutics (NASDAQ:SABS – Get Rating) and BioCardia (NASDAQ:BCDA – Get Rating) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their analyst recommendations, valuation, profitability, risk, dividends, earnings and institutional ownership. Analyst Ratings This is a summary of current ratings and […]
BioCardia (NASDAQ:BCDA – Get Rating) announced its quarterly earnings results on Tuesday. The company reported ($0.20) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.21) by $0.01, Fidelity Earnings reports. BioCardia had a negative return on equity of 72.74% and a negative net margin of 1,237.37%. During the same period in the […]
BioCardia (NASDAQ:BCDA – Get Rating) and Ablynx (OTCMKTS:ABLYF – Get Rating) are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their profitability, valuation, risk, dividends, institutional ownership, analyst recommendations and earnings. Analyst Ratings This is a summary of recent ratings and price targets […]